Discussion
Loading...

Post

  • About
  • Code of conduct
  • Privacy
  • Users
  • Instances
  • About Bonfire
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 5 days ago

Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company's biggest challenge: how to better tap into America's mass market for weight-loss drugs. https://www.japantimes.co.jp/business/2025/10/22/companies/novo-nordisk-board-us-consumers/?utm_medium=Social&utm_source=mastodon #business #companies #wegovy #pharmaceuticals #novonordisk

The Japan Times

Novo's board bust-up to sharpen drugmaker's focus on U.S. consumers

The Danish drugmaker that initially soared on the success of its obesity drug has lost its market lead to U.S. rival Eli Lilly and cheaper copycats.
  • Copy link
  • Flag this post
  • Block
Log in

bonfire.cafe

A space for Bonfire maintainers and contributors to communicate

bonfire.cafe: About · Code of conduct · Privacy · Users · Instances
Bonfire social · 1.0.0-rc.3.21 no JS en
Automatic federation enabled
  • Explore
  • About
  • Members
  • Code of Conduct
Home
Login